A strengthening the reporting of observational studies in epidemiology (STROBE)-Reference-Cited by-同舟云学术

A strengthening the reporting of observational studies in epidemiology (STROBE)

Published:2021-02-05 Issue:5 Volume:100 Page:e24485
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Dellino Miriam,Gargano Giulio,Tinelli Raffele,Carriero Carmine,Minoia Carla,Tetania Skrypets,Silvestris Erica,Loizzi Vera,Paradiso Angelo,Casamassima Porzia,Tufaro Antonio,Cormio Gennaro,Garrisi Vito Michele

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference23 articles.

1. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas;Drapkin;Cancer Res,2005

2. The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass;Montagnana;J Clin Lab Anal,2009

3. Management of presumed benign ovarian tumors: updated French guidelines;Brun;Eur J Obstet Gynecol Reprod Biol,2014

4. Benign conditions associated with raised serum CA-125 concentration;Buamah;J Surg Oncol,2000

5. Is the risk of ovarian malignancy algorithm better than other tests for predicting ovarian malignancy in women with pelvic masses;Yanaranop;Gynecol Obstet Invest,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Study of Quality of Life of Elderly Live Kidney Donors—An Interview-Based Prospective Follow-Up Study;Transplantation Proceedings;2024-09

2. Aggressive Angiomyxoma of the Lower Female Genital Tract: A Review of the MITO Rare Tumors Group;Cancers;2024-03-31

3. Agriculture-Related Occupational Hazards Reporting to Health Facility in Tribal Area: A Retrospective Record-Based Observational Study;D Y Patil Journal of Health Sciences;2024-01

4. A Deep Learning Approach to Classify Surgical Skill in Microsurgery Using Force Data from a Novel Sensorised Surgical Glove;Sensors;2023-11-03

5. Aggressive Angiomyxoma of the Lower Female Genital Tract in Pregnancy: A Review of the MITO Rare Tumors Group;Cancers;2023-06-29